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Introduction 
Over the past two decades, the international scientific 
community engaged in a debate on the opportunity to 
make scientific information of public interest freely 
accessible among researchers worldwide in order to 
speed up the spread of relevant findings. The Ebola 
(2014-2016) and Zika (2015-2016) virus outbreaks 
provided an added sense of urgency to these efforts (1); 
the public health emergency triggered by the COVID-
19 is an issue of international concern and an 
unexpected incentive to the debate. The collaborative 
efforts of practitioners and researchers to find an 
effective solution to the global health crisis have 
highlighted the urge to embrace the adoption of open 
data, open science and new forms of communication. 
From January to June 2020, the fight against the virus 
has produced an unprecedented flood of scientific 
information across the internet with the number of 
COVID-19 papers growing tremendously (2).  Before 
entering formal peer review, a huge amount of new 
findings has been released in the form of preprints through 
platforms such as bioRxiv (https://www.biorxiv.org/) and 
medRxiv (https://www.medrxiv.org/). These preprints 
often receive a great deal of attention on social media: 
on the microblogging site Twitter, the top COVID-19 
preprints have been retweeted over 10,000 times (3).  
At the same time, to support the public health 
emergency efforts to contain the spread of COVID-19, 
publishers have committed to accelerate the 
management of article review processes in order to 
publish papers as quickly as possible. Several publishers 
have made articles on COVID-19 issued in their 
journals available online free of charge, taking on the 
great responsibility of ensuring both quality of contents 
and speed of information. The massive number of 
articles on COVID-19 submitted for publication 
demands skills and new strategies to find balance 
between accuracy, scrupulousness, flexibility and 
urgency of release, and journals are quickly evolving 
their publishing procedures in response to the COVID-
19 health crisis (4).  
One of the consequences of these changes in the 
dissemination of scientific information is that its 
increased speed and volume have made it harder for 
researchers to quickly spot the most relevant findings 
(5). The sharing of scientific and clinical data in a very 
short period of time has led to a serious concern about 
the quality of its contents and the need to rethink the 
peer-review models practiced by science journals. The 
World Health Organization (WHO) has defined the 
dissemination of an over-abundance of information – 
some accurate and some not – occurring during an 
epidemic, with the term “Infodemic” (6). Assuming 
that accurate information must spread at least as fast 
as the virus, it is imperative that those involved in 
communication allow public health information to 
spread faster and in the best possible way.  
COVID-19 has made an impact on work culture in so 
many ways. Video conferencing and virtual training 
have been the new normal during the strict lockdown 
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measures imposed by governments to contain the 
pandemic, and the enormously increased workloads 
have required adaptability and very high level of 
competence. Indeed, with great changes come great 
responsibilities, but opportunities and privileges as 
well. 
This article analyses the influence and changes of 
COVID-19 public health emergency on scientific 
publishing. The authors, editors of the science journal 
Annali dell’Istituto Superiore di Sanità (the official 
Journal of the Italian National Institute of Health), aim 
to provide a point of view for the community of 
librarians and information specialists about publishing 
in the COVID-19 era, according to their expertise on 
the topic. 
 
Science publishing in times of crisis 
During the COVID-19 outbreak, science journals have 
experienced an unprecedented situation: they received 
what many called a “tsunami” of COVID-19 related 
submissions, which eventually lead to a “pandemic” of 
publications (7). Indeed, an analogy between the 
pandemic curve and the growth in the number of 
published papers has been reported by some authors 
(8). This huge increase in the number of new 
publications on this topic mainly affected the most 
prestigious journals. For instance, three to ten times the 
usual number of submissions occurred in The Lancet 
group of prominent journals (9).  
How did the journals react to this pressing demand from 
authors wishing to disseminate, as rapidly as possible, 
new information on the virus? Major publishers could 
count on strong infrastructures and on a wide network 
of international editors and collaborators. But still they 
had to quickly adapt their workflow systems to meet the 
new publication needs. The other scholarly journals, 
published at national or international level, also 
struggled to modify their standards and procedures to 
keep up with the pace. Both categories of journals were 
also facing the challenge of having their own editors and 
staff working from home during the lockdown period, in 
some cases with inadequate technological resources. 
The urgency to publish information and data potentially 
useful to save as many lives as possible, during the first 
weeks of the pandemic, forced editors to consider 
breaking some traditional barriers in the publication 
process. It was clear from the beginning that the first 
data on the virus had to be published with a fast-track 
priority. This in order to help researchers rapidly develop 
their studies, clinicians deal with their patients flocking 
to the emergency departments and governments to 
adopt restrictive measures supported by scientific 
evidence both at national and global level (see, for 
instance, 10). National health institutes rapidly 
produced technical, surveillance or situation reports, 
which often represented the only source of information 
and data to cope with the pandemic at national level.  
Such reports contained precious “raw material” later 
developed in journal articles. 
Under the urgency of the coronavirus crisis, an 
unexpected small revolution occurred in science 
publishing and several ongoing changes and 
developments were further accelerated. At least two 
areas of the publication workflow were affected: the 
peer-reviewing and the dissemination of research results. 
 
Peer-reviewing 
Peer-review has been a keystone in the publication 
process from the times of the Philosophical Transactions 
of the Royal Society of London, at the beginning of the 
nineteenth century (11). Though highly debated for 
decades, this independent critical assessment is still 
considered by the International Committee of Medical 
Journal Editors (ICMJE) as “an intrinsic part of all 
scholarly work, including scientific research, [and] an 
important extension of the scientific process” (12). 
Recently, a general tendency towards a greater openness 
in science is forcing the scholarly publishing community 
to study different – untraditional – forms of open peer-
review, which are currently listed under the so called 
“open peer-review umbrella”. At present, however, the 
great majority of biomedical journals still adopts a 
traditional peer-review system, as shown in a study by 
the same authors of the present paper on the journals 
listed in the Public, Environmental and Occupational 
Health category in the Journal Citation Reports, whose 
results will be presented at the EAHIL Virtual 
Conference which will take place in November 2020 
(13).  
As it is well known, traditional peer-review can be a time-
consuming process. When a manuscript requires more 
than one round of review before being accepted for 
publication, the process can last several months. With 
the pandemic outbreak, these lengthy review times had 
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to be reduced. Editors were rushing to identify papers, 
whose content was potentially useful to fight the virus, 
and publish them as rapidly as possible. They were 
sometimes forced to accelerate the peer-review process 
contracting it even to a few days and authors felt the 
urge to make their papers available in the form of 
preprints (see the following chapter).  
Editors also struggled to find reviewers who would 
accept this task and complete their assignment quickly 
even under stressful conditions. This difficulty caused a 
prolongation in the acceptance of manuscripts and the 
frustration and anger of authors. From the point of view 
of reviewers, those perceived to be experts in the field 
were “inundated” with requests and the strict deadlines 
posed the risk of lowering the quality of the review and 
the spreading of inaccurate, potentially dangerous 
information (14). Some publishers addressed their 
reviewers with a note showing understanding of the 
difficulties encountered by reviewers and offering 
flexibility by postponing the deadlines and specific 
updated guidelines. 
On 27 April 2020, a COVID-19 Publishers Open Letter 
of Intent for Rapid Review (15) was announced by a 
group of publishers and scholarly communications 
organisations to maximize the efficiency of peer-review 
during the pandemic. This initiative, initially comprising 
of eLife, Hindawi, PeerJ, PLOS, Royal Society, F1000 
Research, FAIRsharing, Outbreak Science, and 
PREreview, supported by the Open Access Scholarly 
Publishers Association (OASPA), aimed at ensuring that 
the key works on COVID-19 were “reviewed and 
published as quickly and openly as possible” (16). The 
signatories invited researchers who were willing to 
conduct a rapid peer-review of COVID-19 submissions 
to voluntarily enter the list of potential reviewers. 
As this initiative strongly underlines, the peer-review 
must remain rigorous and efficient, although rapid and 
open. A question then arises: would these new 
circumstances impact the quality and integrity of peer-
review? During the recent EASE Virtual Conference 
held in June 2020 it was debated whether “it is 
acceptable to reduce quality assurance processes in 
order to fast-track important research in times of crisis” 
(17). This delicate matter will be further discussed in the 
scholarly publishing community.  
Two retracted papers published in The Lancet (18) and 
in The New England Journal of Medicine (19), reporting 
studies on hydroxychloroquine based on the same 
datasets which proved to be unreliable, clearly show the 
danger of a publishing system working under pressure. 
In its retraction note The Lancet apologised recalling its 
good faith: “We all entered this collaboration to 
contribute in good faith and at a time of great need 
during the COVID-19 pandemic”. 
Good faith and trust are particularly needed in times of 
crisis when the normal standard processes to ensure 
quality and integrity might necessarily be altered. 
Retraction Watch (https://retractionwatch.com/), a 
website tracking all retracted papers from scholarly 
journals, already lists, from February 2020 as to 26 July 
2020, twenty-six retracted papers with COVID-19 
related content; three temporarily retracted and one 
expression of concern.  
On 10 June 2020, the Canadian Health Libraries 
Association (CHLA/ABSC), the European Association 
for Health Information and Libraries (EAHIL), the 
Australian Library and Information Association/Health 
Libraries Australia (ALIA-HLA) and the US Medical 
Library Association (MLA) addressed a letter to the 
ICMJE with the aim “to encourage journal editors to 
actively seek information specialists as peer-reviewers for 
knowledge synthesis publications and to advocate for 
the recognition of their methodological expertise”. The 
Letter, introduced by C. Lefebvre, was also published in 
JEAHIL (20).  
 
Dissemination of research results 
On 13 March 2020, the National Science and 
Technology Advisors from 12 countries published an 
open access COVID-19 Letter addressed to all 
Members of the Scholarly Publishing Community 
stating “Given the urgency of the situation, it is 
particularly important that scientists and the public can 
access research outcomes as soon as possible. The 
countries listed below urge publishers to voluntarily 
agree to make their COVID-19 and coronavirus related 
publications, and the available data supporting them, 
immediately accessible in PubMed Central and other 
appropriate public repositories, such as the World 
Health Organization’s COVID data base, to support the 
ongoing public health emergency response efforts” (21).  
The response was impressive. After a few days, more 
than 30 leading publishers worldwide committed to 
making all of their COVID-19 and coronavirus-related 
publications, and the available data supporting them, 
immediately accessible in PubMed Central (PMC) and 
40 Journal of EAHIL 2020; Vol. 16 (3): 37-43
Annarita Barbaro, Federica Napolitani Cheyne and Maria Cristina Barbaro 
in other public repositories and to review and publish as 
quickly as possible all the research contributions related 
to this new virus (22). In June 2020 more than 50 
publishers were adhering to this Public Health 
Emergency COVID-19 Initiative, as reported by the 
NLM (www.ncbi.nlm.nih.gov/pmc/about/covid-19/). 
Already during the Ebola and Zika virus outbreaks, a 
statement on data sharing in public health emergencies 
was issued (23). At that time, the journal signatories 
accepted to make content, related to the viruses, free to 
access and to publish in their journals including any data 
or preprint deposited for unrestricted dissemination 
before submission. As stated: “We've joined other global 
health bodies to call for all research data gathered during 
the Zika virus outbreak, and future public health 
emergencies, to be made available as rapidly and openly 
as possible”. However, it is with the COVID-19 
emergency that all the potential benefits of the open 
access became evident because an unprecedented global 
research effort was on its way and an unrestricted and 
immediate dissemination of search results was needed 
(24). Many of the publishers are making their COVID 
related contents only temporarily available for free on 
their platforms, during the course of the pandemic crisis.  
 
The role of preprints  
during the COVID-19 pandemic 
It is now a widespread assumption that the most 
noticeable change that this world health emergency 
brought to the scientific publication field is the rise of 
so-called preprints. Preprints are drafts of research 
papers, archived on specific platforms, that are open for 
public viewing without having undergone a peer review 
and being published. Due to their capacity of spreading 
research findings almost immediately, preprints have 
been, since the beginning of the pandemic, one of the 
main forms of up-to-date information (25).  
Already a consolidated practice in physics and 
mathematics through the arXiv (https://arxiv.org/) 
preprint server, this approach to fast dissemination of 
research through preprints has come to the biomedical 
sciences mainly through the servers bioRxiv and 
medRxiv. These are only the two most prominent of at 
least 44 different archives currently hosting biology 
preprints; most are non-profit, community-based 
repositories, although traditional publishers, such as 
Elsevier (owner of the preprint server SSRN, 
https://www.ssrn.com/index.cfm/en/), are also joining the 
preprint sector (26). 
Historically the use of preprints in many fields 
(especially life sciences) was limited by policies adopted 
by many publishers of refusing to consider manuscripts 
which had been previously posted as preprints for 
publication, but in the last few years this barrier was torn 
down as many of the most prestigious journals have 
abandoned this practice (as an example of the 
acceptance of preprints also in traditional publishing, 
medRxiv was launched last year thanks to a 
collaboration between Yale University and the 
publishers BMJ and Cold Spring Harbor Laboratory 
Press) and so far, 173 journals allow submissions of 
preprints directly transferred from bioRxiv, and over 30 
journals offer opt-in posting of preprints on bioRxiv after 
submission (27). 
bioRxiv and medRxiv were already relatively established 
(bioRxiv was launched in 2013 and medRxiv in mid-
2019) but have experienced an unprecedented level of 
use in the last few months with the emergence of the 
pandemic: as of today (July 27) they, respectively, count 
1,440 and 5,521 preprints on this topic. Over the same 
period 35,154 COVID-19 related papers appeared in 
PubMed. It is interesting to underline that the number 
of COVID-19 preprints (6,961) as a proportion of peer-
reviewed papers (35,154) published since the beginning 
of the year is high (19.8%) in historical context (Table 1). 
Although peer-review is crucial for the validation of 
science, the ongoing outbreak has shown that the speed 
with which preprints can disseminate information 
                                           Ebola                           Zika                             COVID-19 
Preprints                                  74                                     174                                   6,961 
PubMed                                   1,641                                2,187                                35,154 
Percentage                               4.5%                                 7.9%                                 19.8% 
Table 1. Percentage of preprints among scientific publications indexed in PubMed, in relation to three recent disease out-
breaks. Ebola and Zika data from Johansson MD et al. (1); COVID-19 data from PubMed, bioRxiv and meRxiv July 27, 
2020.
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during emergencies is an added value in a peculiar 
situation where the immediacy of information has 
become essential for decision making (28).  
The lack of peer-review revision for preprints can bring 
issues of credibility and misinformation, in many cases 
unintentional. This particular drawback has been 
highlighted during the ongoing pandemic, especially 
after the famous withdrawal, from the preprint server 
bioRxiv, of a study (29) claiming that COVID-19 
contained HIV “insertions”. The withdrawal appears to 
have been prompted by a number of reports from 
scientists from around the world who had access to the 
study because it was placed on a preprint server and 
who signalled this on Twitter and on various science 
blogs (30).  
Reflecting the changing perception of the status of 
preprints compared to traditional articles, PubMed has 
recently launched the NIH Preprint Pilot 
(https://www.ncbi.nlm.nih.gov/pmc/about/nihpreprints
/) during which the National Library of Medicine 
(NLM) will make preprints resulting from research 
funded by the National Institutes of Health (NIH), 
and posted to eligible preprint servers (the preprint 
servers with the highest volume of papers relating to 
COVID-19: medRxiv, bioRxiv, chemRxiv, arXiv, 
Research Square, and SSRN), available via PubMed 
Central (PMC) and, by extension, PubMed. In this 
first phase, the NIH Preprint Pilot aims to focus on 
increasing the discoverability of preprints with NIH 
support relating to the SARS-CoV-2 virus and COVID-
19. 
Another interesting example of the interconnection 
between the traditional publishing system and the 
“innovative” publishing system related to preprints is 
the new MIT Press open-access journal intended to 
review COVID-19 preprints on a fast-tracked timeline, 
in an effort to stop the spread of misinformation. This 
new publication, Rapid Reviews: COVID-19 (RR:C19), 
(https://rapidreviewscovid19.mitpress.mit.edu/) will 
use artificial intelligence to identify the preprints that 
are of most relevance to health officials, clinicians, and 
the public. After being screened by a group of 
volunteers, manuscripts will be evaluated by up to three 
reviewers in a matter of days, and the resulting review 
will be made publicly available (31). Preprints which 
are positively reviewed will then be given the option of 
being included in a so-called “overlay journal” (32), 
which assigns them a DOI and other “publication data” 
allowing them to be cited on the same footing as 
conventionally published articles. 
What seems to emerge from all the new publishing 
initiatives linked to the COVID-19 crisis is the 
emergence of a “fluid” publishing ecosystem where 
preprints are bidirectionally linked to peer-reviewed 
papers, which in turn are bidirectionally linked to post 
publication comments, updates and amendments (33); 
preprints will thus continue to complement published 
papers, rather than competing with them (34). Like 
other trends associated with the current pandemic 
(such as the increase in remote work, virtual meetings, 
and telemedicine) this is a development that has been 
underway for some time but has been dramatically 
accelerated, quickly moving from a marginal position 
to a central one. 
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